Vimarsana
Biggest News Aggregation in the World

Valleyfield Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valleyfield Facility. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valleyfield Facility Today - Breaking & Trending Today

Cannara Biotech Reports Q2 2024 Financial Results - Vimarsana News

Cannara Biotech Reports Q2 2024 Financial Results

Net revenue, increased to $19.7 million in Q2 2024 from $13.0 million in Q2 2023, a 51.0% increase. Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0...

Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter - Cannara Biotech (OTC:LOVFF) - Vimarsana News

Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter - Cannara Biotech (OTC:LOVFF)

Thanks in part to market share gains and increasing demand for high-quality cannabis at an affordable price in Canada, Cannara Biotech Inc. (OTCMKTS: LOVFF), the vertically integrated producer of premium-grade cannabis and derivative product offerings, reported record growth in revenue and net income for its fourth quarter of 2023.

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues - Vimarsana News

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues

Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially,...

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues -December 07, 2023 at 08:31 am EST - Vimarsana News

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues -December 07, 2023 at 08:31 am EST

Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially, Q4 showed significant growth over Q3...

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues - Vimarsana News

Cannara Biotech Reports Fourth Quarter and 2023 Fiscal Year Results: Record Growth and Profitability Continues

Record Q4 and year end net revenues of $18.3 million and $57.6 million, representing a 53% and 60% increase compared to the same periods of 2022 Sequentially,...